Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Introduction: O(6)-methylguanine-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase (IDH) mutation status are important prognostic factors for patients with glioblastoma. There are conflicting reports about a differential topographical distribution of glioblastoma with vs. wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235346/
https://ncbi.nlm.nih.gov/pubmed/32477929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00596
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia